This activity was supported by an educational grant from Alnylam Pharmaceuticals. Please go to <a href="http://academiccme.com/EPCNCFBE" target="_blank" rel="ugc noopener noreferrer">⁠</a><a href="http://academiccme.com/ATTRPod" target="_blank" rel="noopener noreferer">http://academiccme.com/ATTRPod</a> and complete the evaluation to receive your CE/CME Credit. Credit is available through June 25, 2026.

This activity was supported by an educational grant from Alnylam Pharmaceuticals. Please go to ⁠http://academiccme.com/ATTRPod and complete the evaluation to receive your CE/CME Credit. Credit is available through June 25, 2026.

This activity was supported by an educational grant from Alnylam Pharmaceuticals. Please go to&nbsp;<a href="http://academiccme.com/EPCNCFBE" rel="noopener noreferrer">⁠</a><a href="http://academiccme.com/ATTRPod" rel="noopener noreferrer">http://academiccme.com/ATTRPod</a> and complete the evaluation to receive your CE/CME Credit. Credit is available through June 25, 2026.

ACC 2025 Conference Review and Analysis: Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Enjoy Jointly Accredited Continuing Medical Education podcasts developed by AcademicCME in several advancing disease states. These programs are developed to bring the practicing clinician current with the latest science and provide optimal strategies on applying this science to practice

Share ACC 2025 Conference Review and Analysis: Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Sign up to save your podcasts

ACC 2025 Conference Review and Analysis: Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

ACC 2025 Conference Review and Analysis: Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

More shows like AcademicCME Podcast

The Medbullets Step 1 Podcast